[18F]AlF-NOTA-DV1-k-(DV3) for translational CXCR4-targeted molecular imaging

被引：0
|
作者：
Luyten, K. [1 ]
Van Loy, T. [2 ]
Cawthorne, C. [3 ]
Deroose, C. [3 ]
Schols, D. [2 ]
Bormans, G. [1 ]
Cleeren, F. [1 ]
机构：
[1] Katholieke Univ Leuven, Lab Radiopharmaceut Res, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Lab Virol & Chemotherapy, Leuven, Belgium
[3] Katholieke Univ Leuven, Dept Imaging & Pathol, Nucl Med & Mol Imaging, Leuven, Belgium
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0546
引用
收藏
页码：S189 / S190
页数：2
相关论文
共 50 条
  • [41] [68Ga]Pentixafor for CXCR4 Imaging in a PC-3 Prostate Cancer Xenograft Model - comparison with [18F]FDG PET/CT, MRI and ex-vivo receptor expression
    Schwarzenboeck, S. M.
    Stenzel, J.
    Otto, T.
    Kurth, J.
    Polei, S.
    Lindner, T.
    Hohn, A.
    Wester, H.
    Vollmar, B.
    Krause, B. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S39 - S39
  • [42] Preparation and biological evaluation of 2-amino-6-[18F]fluoro-9-(4-hydroxy-3-hydroxy-methylbutyl) purine (6-[18F]FPCV) as a novel PET probe for imaging HSV1-tk reporter gene expression
    Cai, Hancheng
    Yin, Duanzhi
    Zhang, Lan
    Yang, Xlaofeng
    Xu, Xiaoyan
    Liu, Weiguo
    Zheng, Xuesheng
    Zhang, Hong
    Wang, Jing
    Xu, Yuhong
    Cheng, Dengfeng
    Zheng, Mingqiang
    Han, Yanjiang
    Wu, Mingxing
    Wang, Yongxian
    NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (06) : 717 - 725
  • [43] Design, Synthesis, and Evaluation of (4R)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a Novel Positron-Emission Tomography Imaging Agent for Monoacylglycerol Lipase
    Hattori, Yasushi
    Aoyama, Kazunobu
    Maeda, Jun
    Arimura, Naoto
    Takahashi, Yasuko
    Sasaki, Masako
    Fujinaga, Masayuki
    Seki, Chie
    Nagai, Yuji
    Kawamura, Kazunori
    Yamasaki, Tomoteru
    Zhang, Ming-Rong
    Higuchi, Makoto
    Koike, Tatsuki
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (05) : 2362 - 2375
  • [44] Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression
    Prabhakaran, Jaya
    Underwood, Mark D.
    Parsey, Ramin V.
    Arango, Victoria
    Majo, Vattoly J.
    Simpson, Norman R.
    Van Heertum, Ronald
    Mann, J. John
    Kumar, J. S. Dileep
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (04) : 1802 - 1807
  • [45] Radiosynthesis of 3-1{[4-(4-[18F]fluorobenzyl)lpiperazin-1-yl}methyl-1H-pyrrolo[2,3-b]pyridine:: A potential dopamine D4 receptor imaging agent
    Hai-Bin, T
    Duan-Zhi, Y
    Jun-Ling, L
    Lan, Z
    Cun-Fu, Z
    Yong-Xian, W
    Wei, Z
    RADIOCHIMICA ACTA, 2003, 91 (04) : 241 - 245
  • [46] Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl) propan-1-amine
    Shalgunov, Vladimir
    van den Broek, Sara Lopes
    Andersen, Ida Vang
    Raval, Nakul R.
    Schafer, Gabriela
    Barz, Matthias
    Herth, Matthias M.
    Battisti, Umberto M.
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 128
  • [47] Synthesis of 3-{4-(4-[18F]fluorophenyl)piperazin-1-yl]methyl}-1H-pyrrolo[2,3-b]pyridine;: a potential dopamine D4 receptor imaging agent
    Eskola, O
    Bergman, J
    Lehikoinen, P
    Haaparanta, M
    Grönroos, T
    Aalto, S
    Solin, O
    SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1997, 1998, : 367 - 370
  • [48] Synthesis and evaluation of 4-bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targeting imaging agent
    Yamamoto, F
    Aoki, M
    Furusawa, Y
    Ando, K
    Kuwabara, Y
    Masuda, K
    Sasaki, S
    Maeda, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (05) : 616 - 621
  • [49] Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([18F]VUIIS1008) in Glioma
    Dewei Tang
    Michael L. Nickels
    M. Noor Tantawy
    Jason R. Buck
    H. Charles Manning
    Molecular Imaging and Biology, 2014, 16 : 813 - 820
  • [50] Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([18F]VUIIS1008) in Glioma
    Tang, Dewei
    Nickels, Michael L.
    Tantawy, M. Noor
    Buck, Jason R.
    Manning, H. Charles
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (06) : 813 - 820
12345